Perforin-dependent CD4 + T-cell cytotoxicity contributes to control a murine poxvirus infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 25, 2012, Pages 9983-9988

  Fang, Min ^a   Siciliano, Nicholas A ^b   Hersperger, Adam R ^b   Roscoe, Felicia ^a   Hu, Angela ^a   Ma, Xueying ^a   Shamsedeen, Ahamed R ^a   Eisenlohr, Laurence C ^b   Sigal, Luis J ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

CD4 + T lymphocytes; Cytotoxic T lymphocytes; Viral immunology; Viral pathogenesis

Indexed keywords

PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; ECTROMELIA VIRUS; IN VIVO STUDY; LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; POXVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; ECTROMELIA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; PERFORIN;

EID: 84862575241     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1202143109     Document Type: Article

References (44)

1. Billings P, Burakoff S, Dorf ME, Benacerraf B (1977) Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products. J Exp Med 145:1387-1392.
2. Brown DM (2010) Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy. Cell Immunol 262:89-95.
3. Marshall NB, Swain SL (2011) Cytotoxic CD4 T cells in antiviral immunity. J Biomed Biotechnol 2011:954602.
4. Muller D, et al. (1992) LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science 255:1576-1578.
5. Zajac AJ, Quinn DG, Cohen PL, Frelinger JA (1996) Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection. Proc Natl Acad Sci USA 93: 14730-14735.
6. Krensky AM, Ault KA, Reiss CS, Strominger JL, Burakoff SJ (1982) Generation of long-term human cytolytic cell lines with persistent natural killer activity. J Immunol 129:1748-1751.
7. Suni MA, et al. (2001) CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens. Eur J Immunol 31:2512-2520.
8. Jellison ER, Kim SK, Welsh RM (2005) Cutting edge: MHC class II-restricted killing in vivo during viral infection. J Immunol 174:614-618.
9. Brien JD, Uhrlaub JL, Nikolich-Zugich J (2008) West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol 181:8568-8575.
10. Trapani JA, Smyth MJ (2002) Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2:735-747.
11. Trapani JA, et al. (1998) Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase-dependent, but cell death is caspase-independent. J Biol Chem 273:27934-27938.
12. Janssens W, et al. (2003) CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J Immunol 171:4604-4612.
13. Stalder T, Hahn S, Erb P (1994) Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 152:1127-1133.
14. Nikiforow S, Bottomly K, Miller G, Münz C (2003) Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation. J Virol 77:12088-12104.
15. Casazza JP, et al. (2006) Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med 203:2865-2877.
16. Appay V, et al. (2002) Characterization of CD4(+) CTLs ex vivo. J Immunol 168:5954-5958.
17. Brown DM, Dilzer AM, Meents DL, Swain SL (2006) CD4 T cell-mediated protection from lethal influenza: Perforin and antibody-mediated mechanisms give a one-two punch. J Immunol 177:2888-2898.
18. Khanolkar A, Yagita H, Cannon MJ (2001) Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells. Virology 287:79-88.
19. Niiya H, et al. (2005) Differential regulation of perforin expression in human CD4+ and CD8+ cytotoxic T lymphocytes. Exp Hematol 33:811-818.
20. Mitra-Kaushik S, Cruz J, Stern LJ, Ennis FA, TerajimaM (2007) Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses. J Immunol 179:1303-1312.
21. Esteban DJ, Buller RM (2005) Ectromelia virus: The causative agent of mousepox. J Gen Virol 86:2645-2659.
22. Fenner F (1981) Mousepox (infectious ectromelia): Past, present, and future. Lab Anim Sci 31:553-559.
23. Fenner F (1994) Mousepox (ectromelia). Virus Infections of Rodents and Lagomorphs, Virus Infections of Vertebrates, ed Osterhaus A (Elsevier Science, Amsterdam, New York), Vol 5, p 412.
24. Fenner F (1949) Mouse-pox; infectious ectromelia of mice; a review. J Immunol 63:341-373.
25. Fenner F, et al. (1988) Smallpox and its Eradication (World Health Organization, Geneva), p 1460.
26. Flint SJ, Enquist LW, Racaniello VR, Skalka AM (2009) Principles of Virology (ASM Press, Washington, DC), 3rd Ed.
27. Virgin HW (2007) Pathogenesis of viral infection. Fields' Virology, eds Fields BN, Knipe DM, Howley PM (Wolters kluwer/Lippincott Williams & Wilkins, Philadelphia), 5th Ed Vol 1, pp 335-336.
28. Wallace GD, Buller RM (1985) Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL/6j, BALB/cByj and AKR/J inbred mice. Lab Anim Sci 35:41-46.
29. Buller RM, Holmes KL, Hügin A, Frederickson TN, Morse HC, 3rd (1987) Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 328:77-79.
30. Buller RM, Palumbo GJ (1991) Poxvirus pathogenesis. Microbiol Rev 55:80-122.
31. Karupiah G, Buller RM, Van Rooijen N, Duarte CJ, Chen J (1996) Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. J Virol 70:8301-8309.
32. Karupiah G, Fredrickson TN, Holmes KL, Khairallah LH, Buller RM (1993) Importance of interferons in recovery from mousepox. J Virol 67:4214-4226.
33. Parker AK, Parker S, Yokoyama WM, Corbett JA, Buller RM (2007) Induction of natural killer cell responses by ectromelia virus controls infection. J Virol 81:4070-4079.
34. Fang M, Sigal LJ (2005) Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J Immunol 175:6829-6836.
35. Fang M, Sigal LJ (2006) Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host. J Immunol 177:8027-8036.
36. Chaudhri G, Panchanathan V, Bluethmann H, Karupiah G (2006) Obligatory requirement for antibody in recovery from a primary poxvirus infection. J Virol 80:6339-6344.
37. Butler NS, et al. (2012) Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol 13:188-195.
38. McDermott DS, Varga SM (2011) Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think. J Immunol 187:5568-5576.
39. Moutaftsi M, et al. (2007) Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses. J Immunol 178:6814-6820.
40. Sette A, et al. (2008) Selective CD4+ T cell help for antibody responses to a large viral pathogen: Deterministic linkage of specificities. Immunity 28:847-858.
41. Tscharke DC, et al. (2005) Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med 201:95-104.
42. Fang M, Cheng H, Dai Z, Bu Z, Sigal LJ (2006) Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host. Virology 345:231-243.
43. Fang M, Lanier LL, Sigal LJ (2008) A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog 4:e30.
44. Siciliano NA, Skinner JA, Yuk MH (2006) Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response. J Immunol 177:7131-7138.